Cited by 803Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and SignalingDeep Brain Stimulation and Movement Disorders

The DOI matches its Crossref record; 173 of the 176 references it cites were found in a registry or an index.

Parkinson’s disease: genetics and pathogenesis

Shulman, Joshua M., De Jager, Philip L., Feany, Mel B.·2011·Annual Review of Pathology: Mechanisms of Disease

DOI 10.1146/annurev-pathol-011110-130242

Open this paper in CoChat — free account

Abstract

Recent investigation into the mechanisms of Parkinson's disease (PD) has generated remarkable insight while simultaneously challenging traditional conceptual frameworks. Although the disease remains defined clinically by its cardinal motor manifestations and pathologically by midbrain dopaminergic cell loss in association with Lewy bodies, it is now recognized that PD has substantially more widespread impact, causing a host of nonmotor symptoms and associated pathology in multiple regions throughout the nervous system. Further, the discovery and validation of PD-susceptibility genes contradict the historical view that environmental factors predominate, and blur distinctions between familial and sporadic disease. Genetic advances have also promoted the development of improved animal models, highlighted responsible molecular pathways, and revealed mechanistic overlap with other neurodegenerative disorders. In this review, we synthesize emerging lessons on PD pathogenesis from clinical, pathological, and genetic studies toward a unified concept of the disorder that may accelerate the design and testing of the next generation of PD therapies.

Integrity signals

Registry

Crossref · 10.1146/annurev-pathol-011110-130242

Cites

173 of 173 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
α-Synuclein in Lewy bodies
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Parkinson's Disease
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
Epidemiology of Parkinson's disease
de Lau, L. M., & Breteler, M. M. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70471-9 · Cited by 4,110
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836

Show all 176 references

Research works printed but not linked: 4

Parkinson J, 1817, An Essay on the Shaking Palsy
Priyadarshi A, 2000, Neurotoxicology, 21, 435
Gilks W, 2005, Lancet, 365, 415
Nichols WC, 2005, Lancet, 365, 410

Sorted by citations

Items 701–800 of 803

Resting state brain networks and their implications in neurodegenerative disease
Sohn, W. S., Yoo, K., Kim, J., & Jeong, Y. (2012) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2000254
Traumatic Brain Injury and Dopaminergic Degeneration: the long-term Risks Require Greater Attention
Chesselet, M., & Hovda, D. A. (2011) · Neurodegenerative Disease Management · doi:10.2217/nmt.11.71
Juvenile Parkinson disease caused by parkin mutations: large deletions and pathogenic mechanisms
Morais, S. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Aminergic control of Drosophila behavior
Damrau, C. (2015) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-17177
CAMBIOS NEUROPSICOLÓGICOS ASOCIADOS A ESTIMULACIÓN CEREBRAL PROFUNDA EN ENFERMEDAD DE PARKINSON: REVISIÓN TEÓRICA NEUROPSYCHOLOGICAL CHANGES ASSOCIATED WITH DEEP BRAIN STIMULATION OF PARKINSON DISEASE: THEORETICAL REVIEW
Mejía, Ó. M. A., Soto, C. A., & Esguerra, M. (2011)
DENTAL MANAGEMENT OF PATIENTS WITH PARKINSON'S DISEASE
Santhosh, M. P., & Kumar, S. (2015)
Understanding the Role of Sirtuin 3 in a Cell Model of Parkinson's Disease
Lizal, K. E. (2013) · TSpace (University of Toronto)
Role of Aberrant α-Synuclein–Membrane Interactions in Parkinson’s Disease
Griggs, A. M., Ysselstein, D., & Rochet, J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394431-3.00039-0
Investigation of Cis and Trans-acting Transcriptional Regulatory Factors and Signaling Pathways of Parkin
Ao, H. S. (2015) · uO Research (University of Ottawa) · doi:10.20381/ruor-4029
Zebrafish as a translational model of Parkinson's disease : a study of microRNAs
Trollope, L. (2015) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Non-Ergot Dopamine Agonists don't Increase the Risk of Heart Failure in Parkinson's disease Patients. A Meta-Analysis of Randomized Controlled Trials
Vecchis, R. D., & Cantatrione, C. (2016) · Journal of Pharmacovigilance · doi:10.4172/2329-6887.1000197
Salt marsh plants as source of bioactive compounds
Rocha, M. I. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Studies on caspase signaling in microglia
Rodhe, J. (2016) · Figshare
NEXT GENERATION SEQUENCING DATA IN BOVINE: QUALITY CONTROL, IMPUTATION, AND APPLICATION
Larmer, S. G. (2016) · The Atrium (University of Guelph)
Tuning of Neuronal Excitation by a Brain Specific Microrna MIR-128: From Targets to Behavior
Tan, C. L. (2025) · Digital Commons - RU (Rockefeller University) · doi:10.48496/4d01-8n59
1) Translational Research on Neurodegenerative Diseases
Katsuno, M., Banno, H., Suzuki, K., Hashizume, A., Adachi, H., Tanaka, F., & Sobue, G. (2012) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.101.2533
Explanation in contexts of causal complexity
Ross, L. N. (2016) · D-Scholarship@Pitt (University of Pittsburgh)
Molecular mechanisms underlying the neuroprotective effect of IGF-1 in neuroblastoma cells and the pro-metastatic effect of Dph3 in murine melanoma cells
Wang, L. (2013) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/54698
The role of histone locus body (HLB) assembly and the cell cycle in histone mRNA biosynthesis
Terzo, E. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/xt4k-ac20
Preliminary multifactorial analysis of Parkinson's disease
Miller, M. (2014) · doi:10.31390/gradschool_theses.3230
Redox Signalling in Dopaminergic Cell Death and Survival
Ray, A., Verma, A., & Ravindranath, V. (2017) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622888-00210
Functional analysis of the parkinsonism-associated protein FBXO7 (PARK15) in neurons
Dontcheva, G. (2017) · doi:10.53846/goediss-6469
The Impact of Chromosomal Aberrations on the Regulation of Kallikrein 6 Expression in Serous Ovarian Carcinoma
Bayani, J. (2013) · TSpace (University of Toronto)
NEUROSCIENCE FOREFRONT REVIEW DOPAMINE MIDBRAIN NEURONS IN HEALTH AND PARKINSON'S DISEASE: EMERGING ROLES OF VOLTAGE-GATED CALCIUM CHANNELS AND ATP-SENSITIVE POTASSIUM CHANNELS
Dragicevic, E., Schiemann, J. M., & Liss, B. (2015)
Studying the Prevalence and Genetic Contributions to Parkinsonism in Pakistan
Khan, S. (2016) · Griffith Research Online · doi:10.25904/1912/2713
Parkinson Hastalığı ve İlişkili Olduğu Genler
Kurman, Y. (2018) · Düzce Üniversitesi Bilim ve Teknoloji Dergisi · doi:10.29130/dubited.359368
Parkinson’s Disease and Mitochondrial Gene Expression
Kachroo, S. (2017) · Virology & Immunology Journal · doi:10.23880/vij-16000115
Inflammation and Parkinson's disease : the effect of Poly(I:C) in a toxin-based model of Parkinson's disease
Bobyn, J. (2011) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2011-06950
IMAGE DERIVED INPUT FUNCTION FOR BRAIN [11C]TMSX PET IMAGING
Waggan, I. (2019) · UTUPub (University of Turku) · doi:10.13140/rg.2.2.15834.47040
Preclinical Development of Novel Bifunctional Compounds for Parkinson's Disease
Nwabufo, C. K. (2019) · HARVEST (University of Saskatchewan)
In vitro MAO-B Inhibitory Effect of Citrus trifoliata L. via Enzyme Assay and Molecular Docking Study
Kawy, M. A. E., Michel, C. G., Kirollos, F. N., Kerdawy, A. M. E., & Sedeek, M. S. (2019) · Egyptian Journal of Chemistry · doi:10.21608/ejchem.2019.14735.1892
Parkinson’s disease, subthalamic nucleus stimulation, and total hip arthroplasty: A case report
Fideler, K. L., Vajapey, S. P., & Harrison, R. K. (2019) · Current Orthopaedic Practice · doi:10.1097/bco.0000000000000812
Dimensionality Reduction of Attributes in order to Predict Parkinson's Disease Using Linear Model
Raj, D. J. P., & Latha, D. P. P. (2019) · International Conference on Smart Systems and Inventive Technology (ICSSIT) · doi:10.1109/icssit46314.2019.8987846
Estimulación Transcraneal de Corriente Directa en Parkinson
Vega, D. M. P., & da Costa, M. L. G. (2013) · Revista Neurociências · doi:10.34024/rnc.2013.v21.8160
Characterization of Mice with Altered Dopamine Transporter and Vesicular Monoamine Transporter 2 Levels
Masoud, S. T. (2017) · TSpace (University of Toronto)
Maintenance of mitochondrial integrity in midbrain dopaminergic neurons governed by a conserved developmental transcription factorPreprint
Miozzo, F., Stickley, L., Valencia-Alarcón, E. P., Dorcikova, M. M., Petrelli, F., Tas, D., Loncle, N., Nikonenko, I., Dib, P. B., & Nagoshi, E. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.24.219246
NECAB2 participates in an endosomal pathway of mitochondrial stress response at striatal synapsesPreprint
Bueno, D., Dey, P. N., Schacht, T., Wolf, C., Wüllner, V., Morpurgo, E., Rojas-Charry, L., Sessinghaus, L., Leukel, P., Sommer, C., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.15.431234
Development of aptamer technologies for the detection of dopamine and other biological molecules
Walsh, R. (2012) · doi:10.22215/etd/2012-09558
Sirtuins in mechanistic target of rapamycin complex 1 signaling
Burillo, J., Marqués, P., Jiménez, B., González-Blanco, C., Benito, M., & Guillén, C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-814118-2.00012-4
Yeast proteins reversibly aggregate like amphiphilic moleculesPreprint
Dasmeh, P., & Wagner, A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.12.435082
Análise comparativa de neurônios derivados de células-tronco pluripotentes induzidas (iPSC) para avaliar a associação da Doença de Gaucher e Doença de Parkinson
de Araújo, F. T. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.41.2020.tde-15062020-162144
Genetic basis of Parkinson’s disease: a brief review
Aljohani, A. A., Ahmed, A., Bukhary, A., & Nazar, S. (2021) · International Journal of Medicine in Developing Countries · doi:10.24911/ijmdc.51-1612790077
Reference SVA insertion polymorphisms are associated with dopaminergic degeneration in Parkinson’s Disease and differential gene expression in the PPMI cohortPreprint
Pfaff, A. L., Bubb, V. J., Quinn, J. P., & Kõks, S. (2020) · doi:10.21203/rs.3.rs-41600/v1
Activity recognition and bioinspired approaches for robotics in intelligent environments
Ranieri, C. M. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.55.2021.tde-11082021-112227
Naive Pluripotency in Human Attained by Transient Inhibition of mTOR
Li, H. (2019)
INVESTIGATION INTO THE FUNCTIONAL ROLES OF TAU AND ALPHA-SYNUCLEIN IN NEURODEGENERATIVE DISEASE
Morris, M. (2014)
Efeito protetor da hesperidina em um modelo da doença de parkinson induzida por 6-hidroxidopamina em camundongos
Antunes, M. S. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
EV SU QUŞLARINDA PARAZİTLİK EDƏN TİKANBAŞLILARIN (ACANTHOCEPHALA) SİSTEMATİK İCMALI
Rzayev, F. H. O. (2021) · doi:10.36719/2707-1146/2021/01/01/4-13
Faculty Opinions recommendation of Substantia nigra volume loss before basal forebrain degeneration in early Parkinson disease.
Lungu, C., & Ghosh, P. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718002639.793475417
Preface by Randy Schekman
(2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cb.21.100405.100001
Parkinsonism
Jankovic, J. J., Hallett, M., Okun, M. S., Comella, C., Fahn, S., & Goldman, J. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-31071-0.00004-4
Preface
Schekman, R. W. (2012) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cb-28-101112-100001
Faculty Opinions recommendation of Parkin overexpression during aging reduces proteotoxicity, alters mitochondrial dynamics, and extends lifespan.
Cuervo, A. M., & Kaushik, S. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718132852.793484844
Preface
Schekman, R. W. (2011) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cb-27-100311-100001
Mechanistic insights of glucosome condensate formation by stochastic modeling approachesPreprint
Kang, H.-W., Nguyen, L., An, S., & Kyoung, M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.27.497813
The Gene-Environment Nexus: A Holistic Approach to Neurodegenerative Diseases
Abdelzaher, H. M. (2022) · Nutritional neurosciences · doi:10.1007/978-981-16-9205-5_2
Circadian clock disruption promotes the degeneration of dopaminergic neuronsPreprint
Dorcikova, M. M., Duret, L. C., Pottié, E., & Nagoshi, E. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.15.512376
Analysis of Adult Hippocampal Neurogenesis in Neurodegenerative disease
HAN, G. (2022) · Cronfa (Swansea University) · doi:10.23889/suthesis.62147
The Invertebrates and Their Role Parkinson’s Disease Therapy
Ullah, I., Wang, X., & Li, H. (2021) · Austin Journal of Psychiatry and Behavioral Sciences · doi:10.26420/austinjpsychiatrybehavsci.2021.1082
Activation of Ca 2+ phosphatase Calcineurin regulates Parkin translocation to mitochondria and mitophagyPreprint
Marchesan, E., Nardin, A., Mauri, S., Paola, S. D., Chinellato, M., von Stockum, S., Chakraborty, J., Herkenne, S., Basso, V., Schrepfer, E., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.31.526442
Ứng dụng kỹ thuật giải trình tự gen thế hệ mới trong xác định đột biến gen ở bệnh nhân Parkinson
Trần, T. N., Thịnh, T. H., Việt, N. H., Tuấn, P. L. A., & Khánh, T. V. (2023) · Tạp chí Nghiên cứu Y học · doi:10.52852/tcncyh.v164i3.1477
The Role of Brain Derived Neurotrophic Factor (BDNF) in Regulating α-synuclein Pathology in Primary Microglia and Neurons.
Paquette, C. (2023) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2023-15633
An Overview of Different Treatment Approaches to Improve Gait and Balance in Parkinson’s Disease (PD): A Narrative Review
Daftary, R., Haldikar, N., & Pillai, S. (2023) · International Journal of Health Sciences and Research · doi:10.52403/ijhsr.20230824
Merkezi Sinir Sisteminde MSS Mikroglia Mast Hücrelerinin Rolü ve Nörodejeneratif Hastalıklar Açısından Önemi
KUŞAT, T., & Emrah, S. U. R. (2023) · doi:10.59287/sbyc.582
Molecular Pathology of the Central Nervous System
Cotter, J. A., & Hattab, E. M. (2023) · Springer eBooks · doi:10.1007/978-3-031-35118-1_23
Limb Speed Perception Accuracy in Neurodegenerative Disease
Brandmeir, C. L. (2024) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.12362
Geoenvironmental variables as causal cofactors of diseases of unknown etiology
Davies, T. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-818748-7.00013-7
Oxadiazole
Hussain, E. A., Ghani, A., & Sadiq, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-85386-6.00006-8
Working memory circuits and rhythms in cognition in Parkinson's disease
Spicer, M. M., Yeager, B. E., Kim, Y.-C., & Narayanan, N. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15754-7.00043-2
Advancements in Biomaterials for Neuronal Tissue Regeneration: Applications and Future Prospects
Bassi, P., Swami, R., Sharma, T., & Malik, D. S. (2025) · Springer eBooks · doi:10.1007/978-981-97-9959-6_7
Biomaterials for Neuroregeneration: Mechanisms and Therapeutic Applications
Yadav, D., Singh, A. K., & Sharma, P. K. (2025) · Springer eBooks · doi:10.1007/978-981-97-9959-6_5
Environmental Factors Exacerbate Parkinsonian Phenotypes in an Asian-Specific Knock-In LRRK2 Risk Variant in Mice
Bichler, Z., Vanan, S., Zhang, Z., Dong, Q. (., Lee, J. W. L., Zhang, C., Hang, L., Jiang, M. H., Padmanabhan, P., Saw, W. T., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083556
Recognising the phenotype of genetic forms of Parkinson’s disease in clinical practice
Olszewska, D. A., McCarthy, A. J., Fallon, E., & Lynch, T. (2015) · Advances in Clinical Neuroscience & Rehabilitation · doi:10.47795/lcvn1892
The clinical utility of multidisciplinary rehabilitation in individuals with Huntington’s Disease
Cruickshank, T. M. (2015) · Australasian Journal of Paramedicine
Additional file 1 of Erythrocytic α-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson’s disease pathogenesis
Sheng, L., Stewart, T., Yang, D., Thorland, E., Soltys, D., Aro, P., Khrisat, T., Xie, Z., Li, N., Liu, Z., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12629109
Additional file 3 of Choroid and choriocapillaris changes in early-stage Parkinson’s disease: a swept-source optical coherence tomography angiography-based cross-sectional study
Zhang, Y., Yang, L., Gao, Y., Zhang, D., Tao, Y., Xu, H., Chen, Y., Xu, Y., & Zhang, M. (2022) · Figshare · doi:10.6084/m9.figshare.20652772
Additional file 5 of Intestine-derived α-synuclein initiates and aggravates pathogenesis of Parkinson’s disease in Drosophila
Liu, W., Lim, K., & Tan, E.-K. (2022) · Figshare · doi:10.6084/m9.figshare.21351343
Additional file 1 of Oligomerization of Lrrk controls actin severing and α-synuclein neurotoxicity in vivo
Sarkar, S., Bardai, F. H., Olsen, A. L., Lohr, K. M., Zhang, Y.-Y., & Feany, M. Β. (2021) · Figshare · doi:10.6084/m9.figshare.14670513
Self-citation
Additional file 4 of Choroid and choriocapillaris changes in early-stage Parkinson’s disease: a swept-source optical coherence tomography angiography-based cross-sectional study
Zhang, Y., Yang, L., Gao, Y., Zhang, D., Tao, Y., Xu, H., Chen, Y., Xu, Y., & Zhang, M. (2022) · Figshare · doi:10.6084/m9.figshare.20652775
Additional file 2 of Intestine-derived α-synuclein initiates and aggravates pathogenesis of Parkinson’s disease in Drosophila
Liu, W., Lim, K., & Tan, E.-K. (2022) · Figshare · doi:10.6084/m9.figshare.21351334
Additional file 1 of Identification of sixteen novel candidate genes for late onset Parkinson’s disease
Gialluisi, A., Reccia, M. G., Modugno, N., Nutile, T., Lombardi, A., Giovannantonio, L. G. D., Pietracupa, S., Ruggiero, D., Scala, S., Gambardella, S., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14813710
Additional file 1 of Intestine-derived α-synuclein initiates and aggravates pathogenesis of Parkinson’s disease in Drosophila
Liu, W., Lim, K., & Tan, E.-K. (2022) · Figshare · doi:10.6084/m9.figshare.21351331
Additional file 1 of Choroid and choriocapillaris changes in early-stage Parkinson’s disease: a swept-source optical coherence tomography angiography-based cross-sectional study
Zhang, Y., Yang, L., Gao, Y., Zhang, D., Tao, Y., Xu, H., Chen, Y., Xu, Y., & Zhang, M. (2022) · Figshare · doi:10.6084/m9.figshare.20652766
Neuroprotective effects of GLP-2 and a GLP-2/GIP dual receptor agonist in an MPTP-induced mouse model of Parkinson's disease
Feng, P., Liu, Z., Zhai, X., Bai, B., Gao, H., Hao, W., Li, T., & Hölscher, C. (2026) · Peptides · doi:10.1016/j.peptides.2026.171485
Unravelling the multi-target mechanism of methoxylated flavonoids in Parkinson's disease: Insights from network pharmacology and molecular dynamics
Ashok, C., Jeyabalan, S., Pavadai, P., Vignesh, M., Devaraja Dravida Pandiyan, S., Mohan, D., Sugumar, R., Sugumar, R., Sugin Lal Jabaris, S., Subramaniyan, V., et al. (2026) · Toxicology Reports · doi:10.1016/j.toxrep.2026.102248
Conception, synthèse et évaluation de nouveaux ligands antagonistes de récepteurs A2a
Moas-Héloire, V. (2015) · doi:10.70675/874c4424za06cz4d4ez9220za1bce27b4c5a
Impact moléculaire de l’exposition subchronique par voie orale à un pesticide, le paraquat, dans un modèle murin transgénique de synucléinopathie humaine : implication du système nerveux entérique
Naudet, N. (2017) · theses.fr (ABES) · doi:10.70675/926cf85bz2e84z47f3z9201z14ab5a48aa82
Study of neuronal networks and mechanisms implicated in locomotor reactivity and Parkinson's disease pathogenesis in the Drosophila model
Sun, J. (2018) · theses.fr (ABES) · doi:10.70675/ab1bac8ezd1d7z4faczafedzd5f7efbfe78c
Study of the interactions between the nervous system and the gut in Parkinson’s disease using Drosophila
Yue, X. (2022) · theses.fr (ABES) · doi:10.70675/b34b937fz70e7z48a6za103zc4073036f09e
Evaluation of the role of parkin in the direct and indirect transcriptional regulation of alpha-synucléine in Parkinson's disease
dos Santos, L. R. (2023) · theses.fr (ABES) · doi:10.70675/af8ecae9z4b9ez49b2zab71z84776f0e4807
Etude des réseaux moteurs du tronc cérébral impliqués dans l’activité rythmique des muscles des voies aériennes supérieures
Bergé-Laval, V. (2022) · doi:10.70675/113288c1zcad7z4c97z8e66zfa827c1455b2
Retinal Pathology and Synucleinopathy in the Visual Pathway of α‐Synuclein Preformed Fibril Mouse Model of Parkinson's Disease
Zhang, Q., Qian, X., Peng, T., Hou, X., Ma, Z.-Y., Huang, J., Hu, L., & Luo, W. (2026) · Brain and Behavior · doi:10.1002/brb3.71489
Ginsenoside Rg1 alleviates symptoms of Parkinson’s disease in mice through activating PPARγ and inhibiting MAPK signaling
Wu, Y., Du, J., & Zhang, X.-B. (2026) · Journal of Asian Natural Products Research · doi:10.1080/10286020.2026.2644305
Preserved gaze cueing in Parkinson’s disease: Differential temporal modulation of social and non-social attentional orienting
Marotta, A., Corbo, I., Blasutto, B., Favieri, F., Forte, G., Martella, D., Locuratolo, N., Fattapposta, F., & Casagrande, M. (2026) · Behavioural Brain Research · doi:10.1016/j.bbr.2026.116352
Serum levels of thyroid hormones change differently in the onset and progress phases of the experimental model of Parkinson’s disease in rats
Darabi, S., Haghdoost-Yazdi, H., Sofiabadi, M., Esmaeili, M. H., & Delashoob, M. (2025) · Physiology and Pharmacology · doi:10.66224/phypha.29.4.375
Parkinson’s disease diagnosis using machine learning and multimodal biomarkers: A systematic review
Imran, M., Imran, A., & Alshammari, A. A. (2026) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2026.109388
Miniaturized biosensor platforms for early detection of neurodegenerative diseases and their potential for clinical translation
Anıl, İ. U., Sancakli, B., Jaffrezic-Renault, N. J., Halima, H. B., & Sezgintürk, M. K. (2026) · Discover Electrochemistry. · doi:10.1007/s44373-026-00171-w
Parkinson's disease pathogenesis: From molecular insights to novel therapies
Ramli, M. D. C., Abidin, Z. Z., Okunsai, B., Umbar, G. S. A., & Mauta, T. E. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27702-3.00027-3
BindingDB Entry 6157: Novel inhibitors of human DOPA decarboxylase extracted from Euonymus glabra Roxb.
BindingDB (2014) · UC San Diego · doi:10.7270/q2s75f0f
BindingDB Entry 50018579: Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1
BindingDB (2024) · UC San Diego · doi:10.7270/q2vd73pc

Authors: Shulman, J. M., De Jager, P. L., & Feany, M. B.
Affiliations: Broad Institute (US)
Departments of Neurology, Boston, Massachusetts 02115;
Departments of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115;
ORCID: Shulman, Joshua M.
Venue: Annual Review of Pathology: Mechanisms of Disease
Publisher: Annual Reviews
Published: 2011-02-28
Volume: 6
Issue: 1
Pages: 193-222
ISSN: 1553-4006 (ISSN-L)
1553-4014
DOI: 10.1146/annurev-pathol-011110-130242
OpenAlex: W2129917779
Cited by: 801
References: 176
Citations by year: 2026: 10 · 2025: 21 · 2024: 42 · 2023: 34 · 2022: 64 · 2021: 64 · 2020: 46 · 2019: 59 · 2018: 54 · 2017: 59 · 2016: 74 · 2015: 64 · 2014: 56 · 2013: 65 · 2012: 52
FWCI: 8.22
Type: journal article
Language: en
Open access: closed
Locations: Annual Review of Pathology Mechanisms of Disease (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
Keywords: Parkinson's disease, susceptibility genes, pathogenesis, dopaminergic neuron loss, Lewy bodies, non-motor symptoms, animal models, neurodegeneration, molecular pathways
MeSH terms: Animals, Humans, Parkinson Disease, Lewy Bodies, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Parkinson’s disease: genetics and pathogenesis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks